Compare DGICB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DGICB | CTKB |
|---|---|---|
| Founded | 1986 | 1990 |
| Country | United States | United States |
| Employees | 851 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 654.6M | 595.2M |
| IPO Year | N/A | 2021 |
| Metric | DGICB | CTKB |
|---|---|---|
| Price | $19.13 | $3.58 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 416.0 | ★ 887.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $2.26 | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | $8.06 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $13.84 | $2.37 |
| 52 Week High | $20.30 | $6.18 |
| Indicator | DGICB | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 32.60 |
| Support Level | $15.57 | $3.28 |
| Resistance Level | $19.72 | $4.26 |
| Average True Range (ATR) | 0.42 | 0.28 |
| MACD | -0.10 | -0.12 |
| Stochastic Oscillator | 75.11 | 15.77 |
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.